ghk-cu cancer risk ghk cu evidence Noninvasive and Efficient Peptide Delivery by a Novel Biocompatible Ionic Liquid GHK-Cu! Love ya my Reta – ghk-cu cancer risk studies The

Reconstitute 2.5 mL BAC water Concentration 5.0 mg/mL reta + 1.0 mg/mL cag Weekly draw range 0.40-2.40 mL (40-240 units) Typical cycle 24-week ramp + maintenance Dose selector Component Delivery (12.5/2.5 mg Blend) * Volumes above 100 units exceed a standard 1 mL insulin syringe - split into two injections or use a larger syringe

Functional medicine providers may use peptide therapy for leaky gut (intestinal hyperpermeability), IBS, IBD-related symptoms, gastritis or ulcer recovery, post-antibiotic dysbiosis, and chronic GI inflammation

Water Solubility: Because it is highly water-soluble, it is best introduced in the aqueous phase of your formulation at a temperature below 40C to preserve its bioactivity

Continue daily topical application

With fewer restrictions, pharmacies may see expanded flexibility in preparing these substances, pending compliance with all other applicable regulations